Shanghai Pharmaceuticals Holding Co.,Ltd. (601607.SH): Nicorandil Tablets Pass Consistency Evaluation

Stock News

2025/09/18

Shanghai Pharmaceuticals Holding Co.,Ltd. (601607.SH) announced that its subsidiary Shandong Xinyi Pharmaceutical Co., Ltd. (Shandong Xinyi) has received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration for its nicorandil tablets. The drug has successfully passed the consistency evaluation for generic drug quality and efficacy. Nicorandil tablets are used for the treatment of angina pectoris.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1171713651"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1171713651\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1171713651?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-18 15:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1171713651","market":"hk","top_or_hot":-1,"title":"Shanghai Pharmaceuticals Holding Co.,Ltd. (601607.SH): Nicorandil Tablets Pass Consistency Evaluation","media":"Stock News","content":"<p>Shanghai Pharmaceuticals Holding Co.,Ltd. (601607.SH) announced that its subsidiary Shandong Xinyi Pharmaceutical Co., Ltd. (Shandong Xinyi) has received the \"Drug Supplementary Application Approval Notice\" issued by the National Medical Products Administration for its nicorandil tablets. The drug has successfully passed the consistency evaluation for generic drug quality and efficacy. Nicorandil tablets are used for the treatment of angina pectoris.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Pharmaceuticals Holding Co.,Ltd. (601607.SH): Nicorandil Tablets Pass Consistency Evaluation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Pharmaceuticals Holding Co.,Ltd. (601607.SH): Nicorandil Tablets Pass Consistency Evaluation\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2025-09-18 15:56</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shanghai Pharmaceuticals Holding Co.,Ltd. (601607.SH) announced that its subsidiary Shandong Xinyi Pharmaceutical Co., Ltd. (Shandong Xinyi) has received the \"Drug Supplementary Application Approval Notice\" issued by the National Medical Products Administration for its nicorandil tablets. The drug has successfully passed the consistency evaluation for generic drug quality and efficacy. Nicorandil tablets are used for the treatment of angina pectoris.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1197","symbol_name":"保健護理產品經銷商","start_time":0,"source_url":"","article_id":"1171713651","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1171713651","pubTimestamp":1758182206,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Shanghai Pharmaceuticals Holding Co.,Ltd. (601607.SH) announced that its subsidiary Shandong Xinyi Pharmaceutical Co., Ltd. (Shandong Xinyi) has received the \"Drug Supplementary Application Approval...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"601607":"上海医药","BK1197":"保健护理产品经销商","BK0020":"浦东新区","BK0028":"国家队","BK0183":"MSCI概念","BK0209":"零售","BK0188":"融资融券","BK0012":"证金概念","BK0175":"白马股","02607":"上海医药","BK0196":"行业龙头","BK0187":"一线龙头","BK0184":"上海国资改革","BK0099":"上海本地重组","BK0097":"医药电商"},"translate_title":"上海医药控股股份有限公司。（601607.SH）：尼可地尔片通过一致性评价","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"601607":1,"02607":1},"content_text":"Shanghai Pharmaceuticals Holding Co.,Ltd. (601607.SH) announced that its subsidiary Shandong Xinyi Pharmaceutical Co., Ltd. (Shandong Xinyi) has received the \"Drug Supplementary Application Approval Notice\" issued by the National Medical Products Administration for its nicorandil tablets. The drug has successfully passed the consistency evaluation for generic drug quality and efficacy. Nicorandil tablets are used for the treatment of angina pectoris.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}